Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Hematology and Cell Therapy|December 1, 1996
Clinical experience with fludarabine in hemato-oncologyM J Keating, S O'Brien, P McLaughlin, et al.
Seminars in Oncology|October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapiesW Plunkett, V Gandhi, P Huang, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 24, 2000
High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cellsC O Rodriguez, W Plunkett, M T Paff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignanciesD F Kisor, W Plunkett, J Kurtzberg, et al.
Cancer|October 1, 1993
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemiaS Suki, H Kantarjian, V Gandhi, et al.
Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Journal of Clinical Psychology|January 1, 1984
Parents' treatment expectations and attrition from a child psychiatric serviceJ W Plunkett
Seminars in Oncology|August 1, 1995
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cellsV Gandhi, S Mineishi, P Huang, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Pageof 32